Abstract: A fastening system for mounting on a substrate is described. The fastening system comprises a sleeve and an inner element, wherein the sleeve comprises a holding portion, a spreading zone and a drill opening at one of the two ends of the sleeve and a tool opening at the other end, wherein the spreading zone is arranged at least partially between the holding portion and the drill opening, and wherein the inner element is arranged at least partially within the sleeve and is movable relative to the sleeve, and wherein the inner element comprises a drilling portion and an spreading portion, wherein the drilling portion comprises at least one cutting element and the drilling portion projects at least partially out of the drill opening of the sleeve and the spreading portion of the inner element is adapted to expand the spreading zone of the sleeve during a movement of the spreading portion in the sleeve and relative to the sleeve in the direction from the tool opening to the drill opening.

Abstract: System for mounting facade panels, comprising a centring sleeve with a collar and a base and a fastening element with a head, a shaft and a drill bit, wherein the base of the centring sleeve is connected to the rest of the centring sleeve by means of at least one predetermined breaking point and wherein the base comprises an opening in which the shaft of the fastening element is arranged during mounting and wherein the shaft of the fastening element comprises a projection which causes a release of the base at the predetermined breaking point when the fastening element is in a predetermined position relative to the base of the centring sleeve as well as a corresponding mounting method.

Abstract: An aptamer composition is disclosed which has one or more oligonucleotides that include at least one of deoxyribonucleotides, ribonucleotides, derivatives of deoxyribonucleotides, derivatives of ribonucleotides, or mixtures thereof. The aptamer composition has a binding affinity for one or more cellular membrane glycoproteins selected from the group consisting of: intercellular adhesion molecule 1 (ICAM-1), low-density lipoprotein receptor (LDLR) family members, and cadherin-related family member 3 (CDHR3), preferably intercellular adhesion molecule 1 (ICAM-1), and is configured to reduce the binding of one or more human rhinoviruses to the intercellular adhesion molecule 1 (ICAM-1).

Abstract: An aptamer composition is disclosed which has one or more oligonucleotides that include at least one of deoxyribonucleotides, ribonucleotides, derivatives of deoxyribonucleotides, derivatives of ribonucleotides, or mixtures thereof. The aptamer composition has a binding affinity for one or more cellular membrane glycoproteins selected from the group consisting of: intercellular adhesion molecule 1 (ICAM-1), low-density lipoprotein receptor (LDLR) family members, and cadherin-related family member 3 (CDHR3), preferably intercellular adhesion molecule 1 (ICAM-1), and is configured to reduce the binding of one or more human rhinoviruses to the intercellular adhesion molecule 1 (ICAM-1).

Abstract: An aptamer composition is disclosed which has one or more oligonucleotides that include at least one of deoxyribonucleotides, ribonucleotides, derivatives of deoxyribonucleotides, derivatives of ribonucleotides, or mixtures thereof. The aptamer composition has a binding affinity for one or more cellular membrane glycoproteins selected from the group consisting of: intercellular adhesion molecule 1 (ICAM-1), low-density lipoprotein receptor (LDLR) family members, and cadherin-related family member 3 (CDHR3), preferably intercellular adhesion molecule 1 (ICAM-1), and is configured to reduce the binding of one or more human rhinoviruses to the intercellular adhesion molecule 1 (ICAM-1).

Abstract: An aptamer composition is disclosed which has one or more oligonucleotides that include at least one of deoxyribonucleotides, ribonucleotides, derivatives of deoxyribonucleotides, derivatives of ribonucleotides, or mixtures thereof. The aptamer composition has a binding affinity for one or more cellular membrane glycoproteins selected from the group consisting of: intercellular adhesion molecule 1 (ICAM-1), low-density lipoprotein receptor (LDLR) family members, and cadherin-related family member 3 (CDHR3), preferably intercellular adhesion molecule 1 (ICAM-1), and is configured to reduce the binding of one or more human rhinoviruses to the intercellular adhesion molecule 1 (ICAM-1).

Abstract: An aptamer composition is disclosed which has one or more oligonucleotides that include at least one of deoxyribonucleotides, ribonucleotides, derivatives of deoxyribonucleotides, derivatives of ribonucleotides, or mixtures thereof. The aptamer composition has a binding affinity for one or more cellular membrane glycoproteins selected from the group consisting of: intercellular adhesion molecule 1 (ICAM-1), low-density lipoprotein receptor (LDLR) family members, and cadherin-related family member 3 (CDHR3), preferably intercellular adhesion molecule 1 (ICAM-1), and is configured to reduce the binding of one or more human rhinoviruses to the intercellular adhesion molecule 1 (ICAM-1).

Abstract: An aptamer composition is disclosed which has one or more oligonucleotides that include at least one of deoxyribonucleotides, ribonucleotides, derivatives of deoxyribonucleotides, derivatives of ribonucleotides, or mixtures thereof. The aptamer composition has a binding affinity for one or more cellular membrane glycoproteins selected from the group consisting of: intercellular adhesion molecule 1 (ICAM-1), low-density lipoprotein receptor (LDLR) family members, and cadherin-related family member 3 (CDHR3), preferably intercellular adhesion molecule 1 (ICAM-1), and is configured to reduce the binding of one or more human rhinoviruses to the intercellular adhesion molecule 1 (ICAM-1).

Abstract: An aptamer composition is disclosed which has one or more oligonucleotides that include at least one of deoxyribonucleotides, ribonucleotides, derivatives of deoxyribonucleotides, derivatives of ribonucleotides, or mixtures thereof. The aptamer composition has a binding affinity for one or more cellular membrane glycoproteins selected from the group consisting of: intercellular adhesion molecule 1 (ICAM-1), low-density lipoprotein receptor (LDLR) family members, and cadherin-related family member 3 (CDHR3), preferably intercellular adhesion molecule 1 (ICAM-1), and is configured to reduce the binding of one or more human rhinoviruses to the intercellular adhesion molecule 1 (ICAM-1).

Abstract: A method and an apparatus includes the monitoring of a control device. If a critical event occurs during monitoring of the control device, the control device is transferred (20) into a safe state, and it is determined whether a problem solution is available for the event that has occurred by way of a parameter modification of the control device in a problem-solving database. If the problem solution is available, a parameter data set is provided. In this regard, the parameter data set includes parameter information relating to a parameter to be modified of the control device. If the parameter information for the control device is valid, the parameter is modified according to the parameter information and the control device is released from the safe state.

Abstract: A method for monitoring and modifying motor vehicle functions, includes the following steps: ascertaining an anomalous behavior of a function; transmitting the anomalous behavior to a back end; receiving instructions from the back end, the instructions indicating acute measures to be taken in the motor vehicle in order to adequately react to the anomalous behavior of the function; ascertaining a motor vehicle component which is the cause of the anomalous behavior on the basis of the received instructions; converting the motor vehicle component to a degraded configuration which has a limited functional scope; and if the conversion to the degraded configuration is not possible, converting the motor vehicle component to a safe configuration.

Abstract: A method and an apparatus includes the monitoring of a control device. If a critical event occurs during monitoring of the control device, the control device is transferred (20) into a safe state, and it is determined whether a problem solution is available for the event that has occurred by way of a parameter modification of the control device in a problem-solving database. If the problem solution is available, a parameter data set is provided. In this regard, the parameter data set includes parameter information relating to a parameter to be modified of the control device. If the parameter information for the control device is valid, the parameter is modified according to the parameter information and the control device is released from the safe state.

Abstract: A method for monitoring and modifying motor vehicle functions, includes the following steps: ascertaining an anomalous behavior of a function; transmitting the anomalous behavior to a back end; receiving instructions from the back end, the instructions indicating acute measures to be taken in the motor vehicle in order to adequately react to the anomalous behavior of the function; ascertaining a motor vehicle component which is the cause of the anomalous behavior on the basis of the received instructions; converting the motor vehicle component to a degraded configuration which has a limited functional scope; and if the conversion to the degraded configuration is not possible, converting the motor vehicle component to a safe configuration.

Abstract: Multi-use personal care compositions and articles can include a surfactant, a water insoluble hygroscopic fine, fiber, or filament, and a preservative, where such compositions and articles can show an improved preservative property versus unpreserved compositions.

Abstract: Multi-use personal care compositions and articles can include a surfactant, a water insoluble hygroscopic fine, fiber, or filament, and a preservative, where such compositions and articles can show an improved preservative property versus unpreserved compositions.

Abstract: Multi-use personal care compositions and articles can include a surfactant, a water insoluble hygroscopic fine, fiber, or filament, and a preservative, where such compositions and articles can show an improved preservative property versus unpreserved compositions.